Brenda S. Nettles, DNP, MS, ACNP-BC, AOCNP, CNE, discusses how to help maximize quality of life in survivorship. Hear from oncology nursing professionals about what Oncology Nursing Awareness month in May means to them. Veronica Brady, PhD, FNP-BC, discusses the effect of GLP-1 agonist use in patients undergoing treatment for cancer. The theme of this year's meeting "Celebrating Yesterday, Transforming Tomorrow," inspired attendees and presenters. Learn about the impact of an interactive education program on cervical cancer prevention perceptions in Northwest Nigeria. A series of semi-structured interviews revealed a “unique and burdensome” symptom experience among these patients. Dr. McNally shares ONS presentation insights and discusses why she decided to pursue research on stigma in oncology care. Dr. Reb explained how nurses can build a comprehensive, patient-centered approach to address cancer-related fear and worry. Abbey Kaler, APRN, shares insights on training patient advocates to be members of the scientific research team. For patients with prostate cancer and their partners, fear of cancer recurrence is common and affects their quality of life. The presentation highlighted the importance of improving time to radiation treatment for patients with breast cancer. Learn how HCONS is empowering future nursing professionals through the creation of a student board member position. These ONNs go beyond traditional roles to facilitate multidisciplinary care and collaboration through digital platforms. The team presented their implementation process for nadofaragene firadenove at the 50th Annual ONS Congress. Learn how a team implemented education and training on these administration techniques. Nurse Practitioner Scientist shares insights from her research on how nurses can help reduce cervical cancer stigma. Ortiz discussed why realizing the widespread prevalence of trauma is critical in providing trauma-informed care to patients. A nursing team from Tufts Medical Center discusses their case presentation on the use of Reiki in a patient with cGVHD. The treatment landscape for EGFR-mutated NSCLC after TKI treatment represents an area of high unmet need. Immune checkpoint inhibitors have increased survival for patients with NSCLC, however side effect-burden remains significant.